½ÃÀ庸°í¼­
»óǰÄÚµå
1731734

³ú ¸ð´ÏÅ͸µ ±â±â ½ÃÀå : À¯Çüº°, ¿ëµµº°, ¸ð´Þ¸®Æ¼º°, Áö¿ªº°(2026-2032³â)

Brain Monitoring Devices Market By Type (Magnetoencephalography Devices, Intracranial Pressure Monitors, Cerebral Oximeters), By Application, By Modality & Region For 2026-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Verified Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 202 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

³ú ¸ð´ÏÅ͸µ ±â±â ½ÃÀå Æò°¡(2026-2032³â)

½Å°æ ±â¼úÀÇ Áøº¸¿Í ½Å°æ ÁúȯÀÇ À¯º´·üÀÇ »ó½ÂÀº ³ú ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ¿þ¾î·¯ºí EEG °¡Á¬°ú ½Ç½Ã°£ ³ú Ȱµ¿ ¸ð´ÏÅ͸µÀº ÀÇ·á Áø´Ü ¹× ¿¬±¸¿¡ Çõ¸íÀ» °¡Á®¿Ô½À´Ï´Ù. ÀÌ¿¡ µû¶ó ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 73¾ï 6,000¸¸ ´Þ·¯¸¦ ³Ñ¾ú°í 2032³â¿¡´Â ¾à 110¾ï 5,000¸¸ ´Þ·¯¿¡ À̸¦ Àü¸ÁÀÔ´Ï´Ù.

Á¤½Å °Ç°­¿¡ ´ëÇÑ ÀÇ½Ä Áõ°¡¿Í °³ÀÎÈ­µÈ Ä¡·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¿ä±¸´Â ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÇ¾ú½À´Ï´Ù. ÁÖ¿ä ±â¾÷Àº ºñħ½ÀÀûÀÌ°í »ç¿ëÀÚ Ä£È­ÀûÀÎ ÀåÄ¡ °³¹ß¿¡ ÁÖ·ÂÇϰí ȯÀÚÀÇ ´À³¦°ú µ¥ÀÌÅÍÀÇ Á¤È®¼ºÀ» Çâ»ó½Ã۰í ÀÓ»ó ¹× ¼ÒºñÀÚ ºÐ¾ß¿¡¼­ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÕ´Ï´Ù. ³ú ¸ð´ÏÅ͸µ ±â±â¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â 2026³âºÎÅÍ 2032³â±îÁö ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR) 5.74%À» ³ªÅ¸³» ½ÃÀå ¼ºÀåÀ» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù.

³ú ¸ð´ÏÅ͸µ ±â±â ½ÃÀå Á¤ÀÇ/°³¿ä

³ú ¸ð´ÏÅ͸µ ±â±â´Â ³úÆÄ(EEG), ±â´ÉÀû Àڱ⠰ø¸í ¿µ»ó(fMRI) ¶Ç´Â ±âŸ ±â¼úÀ» »ç¿ëÇÏ¿© ½Å°æÇÐÀû °Ç°­ ¹× ÀÎÁö ±â´ÉÀ» ÃßÀûÇÕ´Ï´Ù. ½Å°æ Áúȯ Áø´Ü, ¼ö¼ú Áß ³ú Ȱµ¿ ¸ð´ÏÅ͸µ,ÀÎÁö ±â´É Æò°¡¿¡ »ç¿ëµË´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀº °³Àο¡ ¸Â´Â Ä¡·á °èȹ°ú ÀçȰ¿¡ µµ¿òÀÌ µË´Ï´Ù. ¾ÕÀ¸·Î ³ú ¸ð´ÏÅ͸µ °¡Á¬Àº º¸´Ù Á¤È®ÇÏ°í ºñħ½ÀÀûÀÎ ¹æ½ÄÀ¸·Î °³¼±µÉ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. AI¿Í ¿¬°èÇÏ¿© ½Ç½Ã°£ ºÐ¼®À» ¼öÇàÇÏ¿© Á¤½Å °Ç°­°ú ÀÎÁö ±â´ÉÀ» Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù.

½Å°æ ÁúȯÀÇ ¹ß»ý·ü Áõ°¡´Â ³ú ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇմϱî?

½Å°æÁúȯÀÇ À¯º´·ü »ó½ÂÀº ³ú ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀ» °ßÀÎÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀº ³ú °Ç°­ÀÇ Á¤È®ÇÑ Áø´Ü, Ä¡·á °èȹ, ¸ð´ÏÅ͸µ¿¡ µµ¿òÀÌ µË´Ï´Ù.

³ú ¸ð´ÏÅ͸µ ±â±âÀÇ ³ôÀº ºñ¿ëÀº ³ú ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀÇ ¹æÇذ¡ µÉ±î?

³ú ¸ð´ÏÅ͸µ ±â±âÀÇ ºñ½Ñ ºñ¿ëÀº ½ÃÀå ¼ºÀåÀ» Á¦ÇÑÇÒ ¼ö ÀÖ½À´Ï´Ù. °í°¡ÀÇ Àåºñ´Â ƯÈ÷ °³¹ß µµ»ó±¹°ú ¼Ò±Ô¸ð ÀÇ·á ½Ã¼³¿¡¼­ÀÇ Á¢±Ù¼º°ú ¼ö¿ë¼ºÀ» ÀúÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

±×·¯³ª Áö¼ÓÀûÀÎ °³¹ß°ú Çõ½ÅÀº Àå±âÀûÀ¸·Î ºñ¿ë Àý°¨À» ±â´ëÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

  • ½ÃÀå Á¤ÀÇ
  • ½ÃÀå ¼¼ºÐÈ­
  • Á¶»ç ½ºÄÉÁÙ
  • ÀüÁ¦Á¶°Ç
  • ÇѰè

Á¦2Àå Á¶»ç ¹æ¹ý

  • µ¥ÀÌÅÍ ¸¶ÀÌ´×
  • 2Â÷ Á¶»ç
  • 1Â÷ Á¶»ç
  • Àü¹®°¡ÀÇ Á¶¾ð
  • Ä÷¸®Æ¼ üũ
  • ÃÖÁ¾ ¸®ºä
  • µ¥ÀÌÅÍÀÇ »ï°¢Ãø·®
  • »óÇâ½Ä Á¢±Ù
  • ÇÏÇâ½Ä Á¢±Ù¹ý
  • Á¶»çÀÇ È帧

Á¦3Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀå °³¿ä
  • ¼¼°èÀÇ ³ú ¸ð´ÏÅ͸µ ±â±â ½ÃÀå Áö¿ªº° ºÐ¼®(CAGR%)
  • ¼¼°èÀÇ ³ú ¸ð´ÏÅ͸µ ±â±â ½ÃÀå

¿ëµµº°(¹é¸¸ ´Þ·¯)

  • ¼¼°èÀÇ ³ú ¸ð´ÏÅ͸µ ±â±â ½ÃÀå

¿ëµµº°(ÃµÅæ)

  • ÇâÈÄ ½ÃÀå ±âȸ
  • ¼¼°è ½ÃÀå ³»¿ª

Á¦4Àå ½ÃÀå Àü¸Á

  • ¼¼°èÀÇ ³ú ¸ð´ÏÅ͸µ ±â±â ½ÃÀå

Àü¸Á

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ÀÚµ¿Â÷ »ê¾÷, °ÇÃà ¹× °Ç¼³ »ê¾÷¿¡¼­ÀÇ ¼ö¿ä Áõ°¡

°Ç¼³ »ê¾÷

    • ÇÃ¶ó½ºÆ½ °³ÁúÀÇ ÁÖ¿ä ¿ø·á·Î¼­ÀÇ EPDMÀÇ »ç¿ë
  • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ȯÀ² º¯µ¿
    • EPDM ¼öÀÔ¿¡ ´ëÇÑ ¹Ý´ýÇÎ °ü¼¼ ºÎ°ú

°í¹«

    • ´Ù¸¥ ¿¡Æ¿·» ÇÁ·ÎÇÊ·» µð¿£ ¸ð³ë¸Ó µî

µð¿£ ¸ð³ë¸Ó¸¦ ´ëüÇÏ´Â ÇÕ¼º °í¹«ÀÇ °¡¿ë¼º

  • °¡´É¼º
    • ¹ÙÀÌ¿À Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡
    • ¿­°¡¼Ò¼º °¡È²Á¦(TPV)ÀÇ ¿ëµµ È®´ë

(TPV)

    • Àü±âÀÚµ¿Â÷ Áõ°¡·Î EPDM Á¦Á¶¾÷ü¸¦ À§ÇÑ »õ·Î¿î ±âȸ¸¦ âÃâ

EPDM Á¦Á¶¾÷ü¿¡ »õ·Î¿î ±âȸ¸¦ Á¦°ø

  • Covid19°¡ ¿¡Æ¿·»¡¤ÇÁ·ÎÇÊ·»¡¤µð¿£ ¸ð³ë¸Ó(EPDM) ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâ

(EPDM) ½ÃÀå

  • Porter's Five Forces ºÐ¼®

Á¦5Àå ¼¼°èÀÇ ³ú ¸ð´ÏÅ͸µ ±â±â ½ÃÀå : À¯Çüº°

  • °³¿ä
  • ³úÆÄ °Ë»ç(EEG) ÀåÄ¡
  • Àڱ⠳úÆÄ °Ë»ç(MEG) ÀåÄ¡
  • µÎ°³ ³»¾Ð(ICP) ¸ð´ÏÅÍ
  • ³ú »ê¼Ò Æ÷È­µµ ÃøÁ¤±â

Á¦6Àå ¼¼°èÀÇ ³ú ¸ð´ÏÅ͸µ ±â±â ½ÃÀå : ¿ëµµº°

  • °³¿ä
  • º´¿ø
  • Áø·á¼Ò
  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)

Á¦7Àå ¼¼°èÀÇ ³ú ¸ð´ÏÅ͸µ ±â±â ½ÃÀå : ¸ð´Þ¸®Æ¼º°

  • °³¿ä
  • ÈÞ´ë¿ë ±â±â
  • µ¶¸³Çü ±â±â
  • ¿þ¾î·¯ºí ±â±â
  • Ź»óÇü ±â±â

Á¦8Àå ¼¼°èÀÇ ³ú ¸ð´ÏÅ͸µ ±â±â ½ÃÀå : Áö¿ªº°

  • °³¿ä
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¼¼°è ±âŸ Áö¿ª
    • ¶óƾ¾Æ¸Þ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦9Àå ¼¼°èÀÇ ³ú ¸ð´ÏÅ͸µ ±â±â ½ÃÀå °æÀï ±¸µµ

  • °³¿ä
  • °¢»ç ½ÃÀå ·©Å·
  • ÁÖ¿ä ¹ßÀü Àü·«

Á¦10Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • Natus Medical Incorporated
  • Medtronic plc
  • Koninklijke Philips NV
  • GE Healthcare
  • Siemens Healthineers
  • Compumedics Limited
  • BrainScope Company, Inc.
  • NeuroWave Systems, Inc.

Á¦11Àå ÁÖ¿ä ¹ßÀü

  • Á¦Ç° Ãâ½Ã/°³¹ß
  • ÇÕº´°ú Àμö
  • »ç¾÷ È®´ë
  • ÆÄÆ®³Ê½Ê°ú Á¦ÈÞ

Á¦12Àå ºÎ·Ï

  • °ü·Ã Á¶»ç
KTH 25.06.10

Brain Monitoring Devices Market Valuation - 2026-2032

Advances in neurotechnology and the rising prevalence of neurological illnesses are driving growth in the market for brain monitoring devices. Wearable EEG gadgets and real-time brain activity monitoring are revolutionizing medical diagnoses and research. This is likely to enable the market size surpass USD 7.36 Billion valued in 2024 to reach a valuation of around USD 11.05 Billion by 2032.

Rising mental health awareness, as well as need for individualized treatment solutions, are driving market growth. Key companies are concentrating on developing non-invasive and user-friendly devices to improve patient experience and data accuracy, which will drive market growth in both the clinical and consumer sectors. The rising demand for Brain Monitoring Devices is enabling the market grow at a CAGR of 5.74% from 2026 to 2032.

Brain Monitoring Devices Market: Definition/ Overview

Brain monitoring devices use electroencephalography (EEG), functional magnetic resonance imaging (fMRI), or other technologies to track neurological health and cognitive function. They are used to diagnose neurological illnesses, monitor brain activity during surgical procedures and evaluate cognitive function. These technologies aid in individualized treatment regimens and rehabilitation. In the future, brain monitoring gadgets are projected to improve with more precise, non-invasive ways. They might work with AI to perform real-time analysis and improve mental wellness and cognitive function.

Will Increasing Incidence of Neurological Disorders Boost the Brain Monitoring Devices Market Growth?

The rising prevalence of neurological illnesses is projected to drive the market for brain monitoring devices. As the prevalence of disorders such as epilepsy, stroke and neurodegenerative diseases increases, there is a greater need for sophisticated diagnostic and monitoring tools. These technologies help with accurate diagnosis, treatment planning and monitoring of brain health. The increasing awareness of neurological diseases, combined with technological improvements, drives the usage of brain monitoring devices, propelling market growth.

Will High Cost of Brain Monitoring Devices Hamper the Brain Monitoring Devices Market?

The expensive cost of brain monitoring equipment may limit market growth. Expensive gadgets may hinder accessibility and acceptance, especially in developing countries or in smaller healthcare facilities. High costs might also limit funding for sophisticated technologies in medical contexts.

However, continued developments and technological innovations are expected to result in cost savings over time. As the industry expands and economies of scale are reached, prices may fall, thereby reducing some of these hurdles and driving wider use.

Category-Wise Acumens

Will Increasing Demand Diagnosing and Monitoring Neurological Conditions Drive the Electroencephalography (EEG) Devices Segment?

The growing demand for diagnosing and monitoring neurological diseases will drive expansion in the Electroencephalography (EEG) equipment market. EEG devices are critical for evaluating brain activity, diagnosing epilepsy, sleep problems and other neurological conditions.

As the prevalence of such illnesses increases, so does the demand for accurate and trustworthy diagnostic instruments such as EEG machines. Furthermore, advances in EEG technology and increasing awareness of neurological health are projected to drive adoption and growth in this category.

Will Increasing Comprehensive Patient Care Drive the Hospitals Segment?

Providing more comprehensive patient care will drive growth in the hospital segment. Hospitals are strengthening their capacities to deliver comprehensive and integrated care, which includes modern diagnostics and continuous patient monitoring. This trend includes the use of sophisticated brain monitoring equipment to increase diagnostic accuracy and treatment efficacy in neurological diseases.

As hospitals improve their services to match better patient care standards, the demand for advanced brain monitoring technologies, such as EEG and other diagnostic instruments, is projected to rise, accelerating the segment's growth.

Country/Region-wise Acumens

Will Increasing Advanced Healthcare Infrastructure Drive the Market in North America?

The market for brain monitoring devices in North America will be driven by advancements in healthcare infrastructure. The region's established healthcare infrastructure and continued investments in cutting-edge medical technology improve diagnostic and treatment capacities.

Advanced infrastructure promotes the use of advanced brain monitoring devices, allowing for early and accurate diagnostics of neurological diseases. As hospitals and medical facilities incorporate these technologies into their procedures, demand for brain monitoring devices is likely to surge, accelerating market growth in North America.

Will Rising Neurological Disorder Prevalence Drive the Market in Asia Pacific Region?

The rising incidence of neurological disorders will drive the Asia-Pacific brain monitoring device market. The rising prevalence of disorders like epilepsy, stroke and neurodegenerative diseases drives demand for better diagnostic technologies.

As the region's healthcare spending increase and access to medical technologies improves, the necessity for effective brain monitoring solutions grows. This tendency, together with growing healthcare infrastructure and awareness, is likely to significantly enhance the market for brain monitoring devices in Asia-Pacific.

Competitive Landscape

The Brain Monitoring Devices Market is a dynamic and competitive space, characterized by a diverse range of players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions and political support. The organizations are focusing on innovating their product line to serve the vast population in diverse regions.

Some of the prominent players operating in the Brain Monitoring Devices Market include:

Natus Medical Incorporated, Medtronic plc, Koninklijke Philips N.V., GE Healthcare, Siemens Healthineers, Compumedics Limited, BrainScope Company, Inc., NeuroWave Systems, Inc., Nihon Kohden Corporation, Cadwell Industries, Inc., Elekta AB, Advanced Brain Monitoring, CAS Medical Systems, Inc., NCC Medical Co., Ltd., and Neurosoft.

Latest Developments

In December 2023, Nihon Kohden launched the One View feature for its Neuromaster G1 intraoperative neuromonitoring (IONM) system. The IONM program incorporates the patient's anesthetic, vital indicators (e.g., heart rate, SpO2, temperature) and neurological data.

In October 2022, Medtronic is taking bold new measures to change that by opening the Medtronic Neurovascular Co-Lab. An innovation method and venue for new ideas in stroke treatment.

Brain Monitoring Devices Market, By Category

  • Type:
  • Electroencephalography (EEG) Devices
  • Magnetoencephalography (MEG) Devices
  • Intracranial Pressure (ICP) Monitors
  • Cerebral Oximeters
  • Application:
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Modality:
  • Portable Devices
  • Standalone Devices
  • Wearable Devices
  • Tabletop Devices
  • Region:
  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East & Africa

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 MARKET DEFINITION
  • 1.2 MARKET SEGMENTATION
  • 1.3 RESEARCH TIMELINES
  • 1.4 ASSUMPTIONS
  • 1.5 LIMITATIONS

2 RESEARCH METHODOLOGY

  • 2.1 DATA MINING
  • 2.2 SECONDARY RESEARCH
  • 2.3 PRIMARY RESEARCH
  • 2.4 SUBJECT MATTER EXPERT ADVICE
  • 2.5 QUALITY CHECK
  • 2.6 FINAL REVIEW
  • 2.7 DATA TRIANGULATION
  • 2.8 BOTTOM-UP APPROACH
  • 2.9 TOP-DOWN APPROACH
  • 2.10 RESEARCH FLOW

3 EXECUTIVE SUMMARY

  • 3.1 MARKET OVERVIEW
  • 3.2 GLOBAL BRAIN MONITORING DEVICES MARKET GEOGRAPHICAL ANALYSIS (CAGR %)
  • 3.3 GLOBAL BRAIN MONITORING DEVICES MARKET,

BY APPLICATION (USD MILLION)

  • 3.4 GLOBAL BRAIN MONITORING DEVICES MARKET,

BY APPLICATION (K TONS)

  • 3.5 FUTURE MARKET OPPORTUNITIES
  • 3.6 GLOBAL MARKET SPLIT

4 MARKET OUTLOOK

  • 4.1 GLOBAL BRAIN MONITORING DEVICES MARKET

OUTLOOK

  • 4.2 MARKET DRIVERS
    • 4.2.1 RISING DEMAND FROM AUTOMOTIVE AND BUILDING &

CONSTRUCTION INDUSTRY

    • 4.2.2 USE OF EPDM AS A MAJOR RAW MATERIAL FOR PLASTIC MODIFICATION
  • 4.3 RESTRAINTS
    • 4.3.1 FLUCTUATIONS IN THE CURRENCY EXCHANGE RATES
    • 4.3.2 IMPOSITION OF ANTI-DUMPING DUTY ON IMPORTS OF EPDM

RUBBER

    • 4.3.3 AVAILABILITY OF SUBSTITUTES FOR ETHYLENE PROPYLENE

DIENE MONOMER, SUCH AS OTHER SYNTHETIC RUBBERS

  • 4.4 OPPORTUNITIES
    • 4.4.1 INCREASING DEMAND FOR BIO-BASED PRODUCTS
    • 4.4.2 GROWING APPLICATION OF THERMOPLASTIC VULCANIZATES

(TPV)

    • 4.4.3 AN INCREASE IN ELECTRIC VEHICLES WILL FURTHER CREATE

NEW OPPORTUNITIES FOR EPDM MANUFACTURERS

  • 4.5 IMPACT OF COVID19 ON ETHYLENE PROPYLENE DIENE MONOMER

(EPDM) MARKET

  • 4.6 PORTER'S FIVE FORCES ANALYSIS

5 GLOBAL BRAIN MONITORING DEVICES MARKET, BY TYPE

  • 5.1 Overview
  • 5.2 Electroencephalography (EEG) Devices
  • 5.3 Magnetoencephalography (MEG) Devices
  • 5.4 Intracranial Pressure (ICP) Monitors
  • 5.5 Cerebral Oximeters

6 GLOBAL BRAIN MONITORING DEVICES MARKET, BY APPLICATION

  • 6.1 Overview
  • 6.2 Hospitals
  • 6.3 Clinics
  • 6.4 Ambulatory Surgical Centers

7 GLOBAL BRAIN MONITORING DEVICES MARKET, BY MODALITY

  • 7.1 Overview
  • 7.2 Portable Devices
  • 7.3 Standalone Devices
  • 7.4 Wearable Devices
  • 7.5 Tabletop Devices

8 GLOBAL BRAIN MONITORING DEVICES MARKET, BY GEOGRAPHY

  • 8.1 Overview
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 U.K.
    • 8.3.3 France
    • 8.3.4 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Rest of Asia Pacific
  • 8.5 Rest of the World
    • 8.5.1 Latin America
    • 8.5.2 Middle East and Africa

9 GLOBAL BRAIN MONITORING DEVICES MARKET COMPETITIVE LANDSCAPE

  • 9.1 Overview
  • 9.2 Company Market Ranking
  • 9.3 Key Development Strategies

10 COMPANY PROFILES

  • 10.1 Natus Medical Incorporated
    • 10.1.1 Overview
    • 10.1.2 Financial Performance
    • 10.1.3 Product Outlook
    • 10.1.4 Key Developments
  • 10.2 Medtronic plc
    • 10.2.1 Overview
    • 10.2.2 Financial Performance
    • 10.2.3 Product Outlook
    • 10.2.4 Key Developments
  • 10.3 Koninklijke Philips N.V.
    • 10.3.1 Overview
    • 10.3.2 Financial Performance
    • 10.3.3 Product Outlook
    • 10.3.4 Key Developments
  • 10.4 GE Healthcare
    • 10.4.1 Overview
    • 10.4.2 Financial Performance
    • 10.4.3 Product Outlook
    • 10.4.4 Key Developments
  • 10.5 Siemens Healthineers
    • 10.5.1 Overview
    • 10.5.2 Financial Performance
    • 10.5.3 Product Outlook
    • 10.5.4 Key Developments
  • 10.6 Compumedics Limited
    • 10.6.1 Overview
    • 10.6.2 Financial Performance
    • 10.6.3 Product Outlook
    • 10.6.4 Key Developments
  • 10.7 BrainScope Company, Inc.
    • 10.7.1 Overview
    • 10.7.2 Financial Performance
    • 10.7.3 Product Outlook
    • 10.7.4 Key Developments
  • 10.8 NeuroWave Systems, Inc.
    • 10.8.1 Overview
    • 10.8.2 Financial Performance
    • 10.8.3 Product Outlook
    • 10.8.4 Key Developments

11 KEY DEVELOPMENTS

  • 11.1 Product Launches/Developments
  • 11.2 Mergers and Acquisitions
  • 11.3 Business Expansions
  • 11.4 Partnerships and Collaborations

12 Appendix

  • 12.1 Related Research
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦